Experience

Apollomics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Executive Director/Head of Translational Medicine

  • Oct 2018 - Present



MedImmune-A member of the AstraZeneca Group

• Gaithersburg, Maryland, USA

• Diagnostic Expert-Oncology Translational Medicine

  • Feb 2016 - Sep 2018



Dako North America-Agilent Technologies

• Carpinteria-Santa Barbara, California

• Scientific and clinical lead, Companion Diagnostics

  • Feb 2012 - Feb 2016

  Developed PD-L1 companion diagnostic. Clinical biomarker study design and protocol development. Cancer companion diagnostic product development. Design control process and implementation. Class III IVD regulatory filing. Developed PD-L1 companion diagnostic. Clinical biomarker study design and protocol development. Cancer companion diagnostic product development. Design control process and implementation. Class III IVD regulatory filing.



Amgen Inc.

• Principal Scientist, Oncology Research

  • Feb 2000 - Jan 2012

  Led oncology early discovery to late-stage preclinical programes. Strong track record of progressing projects in both small molecule and protein therapeutic modalities. Key projects include development of AKT/PKB kinase inhibitors and antibody-drug-conjugates of novel targets. Successful Mentor of experienced scientists, and manager of multidisciplinary project teams.

• Postdoctoral Research Fellow

  • Nov 1997 - Feb 2000

  Investigated functional and biochemical activities of human telomerase enzyme (hTERT) in cancer maintenance and survival, and the mechanisms for the alternative regulation of telomerase activities by tumor cells.